Three-dimensional platform for patient-derived ovarian cancer tissue
Research type
Research Study
Full title
The development of three-dimensional platform for patient-derived ovarian cancer tissue remodelling.
IRAS ID
299153
Contact name
TK Madhuri
Contact email
Sponsor organisation
Royal Surrey NHS Foundation Trust
Duration of Study in the UK
0 years, 3 months, 19 days
Research summary
In the UK alone, there were 7470 new cases reported in 2015 with 4116 deaths in 2016 and the numbers continue to steadily increase. The current standard treatment of ovarian cancer includes a combination of surgery and chemotherapy. We would like to analyse cancer tissue if the cancer is being removed during surgery –a small piece of the tumour-of many patients with suspected diagnosis of cancer and confirmed cancer and attempt to grow these cancer cells in 3D models (scaffolds) in the laboratory to develop a way of understanding how cancer cells in each individual patient respond to treatment in order to personalise cancer care for the future.
REC name
West of Scotland REC 5
REC reference
21/WS/0059
Date of REC Opinion
12 May 2021
REC opinion
Favourable Opinion